Qritive Secures Multi-Year Contracts with Metropolis Healthcare, CŌRE Diagnostics and Rajiv Gandhi Cancer Institute to Drive AI Adoption in Pathology Across India
QritiveTM , a leading provider of AI solutions for pathology labs worldwide, announces partnership with esteemed diagnostic centres and hospitals in India: Metropolis Healthcare, Rajiv Gandhi Cancer Institute and CŌRE Diagnostics.
- QritiveTM , a leading provider of AI solutions for pathology labs worldwide, announces partnership with esteemed diagnostic centres and hospitals in India: Metropolis Healthcare, Rajiv Gandhi Cancer Institute and CŌRE Diagnostics.
- These institutions have embraced PantheonTM image management system (IMS) and Qritive's AI products, marking them as trailblazers in adoption of artificial intelligence in pathology workflows.
- Mr Surendran Chemmenkottil, CEO, Metropolis Healthcare, stated: “As we embark on this transformative journey with Qritive, we are enthusiastic about immense potential it holds for advancing our capabilities in pathology.
- “We're thrilled to partner with Qritive, integrating their advanced AI solutions into our pathology workflow at CŌRE Diagnostics.